Showing results (871-880 of 1,396) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|July 11, 2024
Diagnostic and Practical Challenges in Applying National Comprehensive Cancer Network Guidelines for Suspected Pathogenic TP53 MosaicismDaniel I Nathan, Tehilla Brander, Julie Gold, et al.
JCO Precision Oncology|July 11, 2024
EGFR V834L and L858R Comutation Is Associated With Response to Osimertinib in Non-Small-Cell Lung CancerNicholas P Giustini, Colin C Pritchard, Nikhil V Kamat, et al.
JCO Precision Oncology|July 11, 2024
Clinical Response to Olaparib in a Patient With Leptomeningeal Carcinomatosis in Newly Diagnosed Breast Cancer With Germline BRCA2 MutationManali Shah, Jeremy Green, Rachel Hudacko, et al.
JCO Precision Oncology|July 11, 2024
Disparate Rates of Germline Variants in Cancer Predisposition Genes in African American/Black Compared With Non-Hispanic White Individuals Between 2015 and 2022Rachel B Wyatt Castillo, Sarah M Nielsen, Elaine Chen, et al.
JCO Precision Oncology|May 16, 2024
RET Alterations Differentiate Molecular Profile of Medullary Thyroid CancerKumar Prabhash, Elveera Saldanha, Vijay Patil, et al.
JCO Precision Oncology|August 25, 2023
Efficacy of Immune Checkpoint Inhibition and Cytotoxic Chemotherapy in Mismatch Repair-Deficient and Microsatellite Instability-High Pancreatic Cancer: Mayo Clinic ExperienceTucker Coston, Aakash Desai, Hani Babiker, et al.
JCO Precision Oncology|August 25, 2023
Race-Associated Genomic Correlates of Therapeutic Response in African American Patients With Non-Small-Cell Lung CancerPin Li, Kaitlyn Kane, Frank M Wolf, et al.
JCO Precision Oncology|September 22, 2023
Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide CohortTessa G Steenbruggen, Denise M Wolf, Bram Thijssen, et al.
JCO Precision Oncology|September 22, 2023
Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian CancerTiffany Y Sia, Anna Maio, Yelena M Kemel, et al.
JCO Precision Oncology|September 28, 2023
Pan-Cancer Analysis of Copy-Number Features Identifies Recurrent Signatures and a Homologous Recombination Deficiency Biomarker to Predict Poly (ADP-Ribose) Polymerase Inhibitor ResponseJay A Moore, Kuei-Ting Chen, Russell Madison, et al.
Pageof 140